NCT02016742View on ClinicalTrials.gov

A Phase 1 Study of the Pharmacokinetics of RDC5 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Healthy Volunteers
Interventions
DRUG

RDC5

Trial Locations (1)

CF48 4DR

Simbec Research Ltd, Merthyr Tydfil

Sponsors
All Listed Sponsors
lead

Chronos Therapeutics Ltd

INDUSTRY